Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Can Hyliion Holdings Tell a Story That Stands Out in a Crowded Field?

Hyliion bulls should be more comfortable with HYLN stock trading in the teens. At that price, it’s much easier to embrace the uncertainty.

CIIG Merger May Be a Short-Term Victim of Last Year’s Success

You may be interested in buying CIIC stock, but prudence may be warranted to make sure the weak hands leave the stock.

The Opportunity May Just Be Getting Started For Moderna

If you’re interested in buying this dip in Moderna, it’s important to understand that you’re investing in mRNA technology more than MRNA stock.

Airbnb Stock Might Sustain These Prices, but They’re Just not Attractive

Airbnb stock may become more attractive after the lockup period ends. But how low does the stock need to go for bullish investors to buy?

7 Music Stocks to Buy in Lieu of Live Shows

The global pandemic has interrupted the growth of digital music, but that looks to change. Here are 7 music stocks to buy for when the parties begin again.